Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
kabonk's Profile
Displaying 1-50 of 238 result(s).
CYDY CytoDyn Inc
05/07/2025 10:35:48 AM
Thanks. You're the best. I forgot a (11)
CYDY CytoDyn Inc
05/06/2025 11:44:03 PM
Not sure if they ever disclosed rec (5)
CYDY CytoDyn Inc
05/05/2025 2:28:23 PM
CCR5 bound by leronlimab would have (5)
CYDY CytoDyn Inc
08/20/2024 3:41:55 PM
Agree, there is lots of jibberish o (8)
CYDY CytoDyn Inc
08/13/2024 4:52:30 PM
Agree with you that the primary end (15)
CYDY CytoDyn Inc
08/13/2024 1:33:54 PM
Q: Are we hoping to improve upon th (11)
CYDY CytoDyn Inc
06/04/2024 12:08:14 PM
No, VIR is developing broadly neutr (7)
CYDY CytoDyn Inc
05/16/2024 3:07:46 PM
Ha, good questions and observations (1)
CYDY CytoDyn Inc
05/16/2024 2:34:44 PM
I wondered the same (new priority o (4)
CYDY CytoDyn Inc
05/16/2024 1:39:46 PM
Good to see some progress on trial (4)
CYDY CytoDyn Inc
05/15/2023 3:02:38 PM
It's nice that pubmed links to the (2)
CYDY CytoDyn Inc
05/15/2023 2:09:25 PM
Except the mice with disabled CCR5 (5)
CYDY CytoDyn Inc
12/19/2022 4:10:16 PM
Stiff person's syndrome neurodiagno (5)
CYDY CytoDyn Inc
12/14/2022 11:14:13 PM
Lipid nanoparticles encapsulation l (4)
CYDY CytoDyn Inc
12/14/2022 4:19:42 PM
Only problem with AAV transgene pro (9)
CYDY CytoDyn Inc
10/28/2022 10:36:32 PM
HIV patients with NASH is an area o
CYDY CytoDyn Inc
08/08/2022 10:59:26 PM
Hahaha, a rhetorical question. For (1)
CYDY CytoDyn Inc
08/03/2022 9:06:33 AM
Sorry .. can't edit on phone .. thi
CYDY CytoDyn Inc
08/03/2022 9:00:54 AM
I think the Sasha grant was a Cente
CYDY CytoDyn Inc
07/27/2022 6:25:59 PM
Nice writeup. In the news recently (7)
CYDY CytoDyn Inc
07/11/2022 12:25:58 PM
This will be in monkeys, like Sacha (6)
CYDY CytoDyn Inc
07/05/2022 5:37:52 PM
Yes I think they have already had s (1)
CYDY CytoDyn Inc
07/05/2022 8:08:07 AM
Unfortunately, AAV is not currently (4)
CYDY CytoDyn Inc
07/05/2022 12:44:26 AM
No, only one daughter cell would ge (3)
CYDY CytoDyn Inc
05/13/2022 2:37:48 PM
FDA is another corrupt failed burea (3)
CYDY CytoDyn Inc
04/01/2022 1:57:30 PM
The reason for the clinical hold wa (2)
CYDY CytoDyn Inc
03/31/2022 9:08:19 PM
Nice .. 7 years of safe monotherapy (3)
CYDY CytoDyn Inc
02/28/2022 4:27:24 PM
Well, the analysis probably is wron (6)
CYDY CytoDyn Inc
02/28/2022 2:32:57 PM
Great question, and it's too bad th (8)
CYDY CytoDyn Inc
02/17/2022 5:46:12 PM
Dark matter is not repulsive. Not s (1)
CYDY CytoDyn Inc
02/17/2022 5:27:41 PM
For the record, Rathke admitted to (1)
CYDY CytoDyn Inc
02/17/2022 4:49:29 PM
No, take a closer look at it. Take (3)
CYDY CytoDyn Inc
02/17/2022 3:53:32 PM
Forever is a very long time for a s (4)
CYDY CytoDyn Inc
02/17/2022 3:42:20 PM
Another review article from that si (5)
CYDY CytoDyn Inc
02/16/2022 1:01:19 PM
There are some long lived memory T- (1)
CYDY CytoDyn Inc
02/15/2022 2:38:37 PM
Patterson recently posted prelimina (7)
CYDY CytoDyn Inc
02/14/2022 12:00:41 PM
Nice review of chemokine signaling (6)
CYDY CytoDyn Inc
02/02/2022 12:37:39 PM
Lots of options/possibilities for f
CYDY CytoDyn Inc
02/02/2022 12:08:16 PM
I wonder if this financing is someh
CYDY CytoDyn Inc
01/31/2022 4:40:40 PM
They stopped recruiting for all the (8)
CYDY CytoDyn Inc
01/28/2022 2:11:50 PM
Which part do you take as speculati (1)
CYDY CytoDyn Inc
01/28/2022 1:46:28 PM
The 11/27/22 8-K says (b) On Januar (3)
CYDY CytoDyn Inc
01/28/2022 12:43:33 PM
Thanks for pulling this out. One ve (1)
CYDY CytoDyn Inc
01/26/2022 9:43:41 PM
Bingo: Its possible that the cytoki (4)
CYDY CytoDyn Inc
01/25/2022 11:33:51 AM
Several other therapies that work . (2)
CYDY CytoDyn Inc
01/20/2022 11:24:12 AM
Canceled CC, waiting for updates on (5)
CYDY CytoDyn Inc
01/15/2022 1:57:59 PM
Cash bond is because Amarex claims (3)
CYDY CytoDyn Inc
01/12/2022 1:15:58 PM
Nice article. Agree that Omicron in (7)
CYDY CytoDyn Inc
01/11/2022 11:31:08 AM
Unfortunately, 10-Q page 35 says: I (4)
CYDY CytoDyn Inc
01/10/2022 11:40:15 AM
Regnum is now run by Anne Kirby, fo (3)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >
Deliver breaking news, insightful commentary, and exclusive reports. Get in touch benzingaheadline@gmail.com. Target readers who trust our platform to stay ahead of the curve.

Recent Articles

  • BYD's European Expansion Plans and Ambitious Roadmap Ahead
  • Qubrid AI Unveils Innovative Accelerator for Startups
  • Sustainable Solutions Drive Growth in the Leather Chemicals Sector
  • Medical Malpractice Losses Surge by $4 Billion Amid Inflation
  • West Monroe Welcomes Accenture's John Rosato as Leader
  • Discovering Provenance Bourbon: A New Era in Whiskey Crafting
  • Saol Therapeutics Navigates FDA Response for PDCD Treatment
  • FG Communities Expands Affordable Housing Portfolio with New Acquisition
  • Shiba Inu Sees Explosive Growth with Record Burn Rate
  • Creative Realities Firmly Stands Against Patent Allegations
  • Discover the Inaugural Nuclear Innovation Summit's Highlights
  • Investing $100 in Boston Scientific: A Decade of Growth
  • Leadership Changes Shape Future of Health Insurance Solutions
  • Gallaher Companies Elevates Senior Living with New Launch
  • Miami International Holdings: A Leader in Options Market Growth
  • Analyzing FTAI Aviation's Short Interest Trends and Insights
  • Understanding the Impact of Short Selling on EnerSys Stock
  • Investors' Insights into Scholar Rock Holding's Performance
  • Anticipating Earnings: Insights on Cognyte Software's Future
  • Upcoming Earnings for Lands' End: What to Expect
  • Creative Realities Stands Strong Against Patent Claims
  • Lakeland Industries Keeps Investors Guessing Before Earnings
  • MIND Technology Set to Shine: Earnings Expectations Unveiled
  • Insightful Earnings Expectations for Skillsoft Corp (SKIL)
  • Anticipating Bioceres Crop Solutions Earnings Report Insights
  • Methode Electronics Prepares for Anticipated Earnings Release
  • FuelCell Energy's Earnings Outlook: What Investors Need to Know
  • Designer Brands Financial Update: Earnings Insights and Analysis
  • Limoneira Earnings Forecast: Analyst Insights and Market Trends
  • Gee Automotive Companies Shines as a Top Employer on Latest List
  • Delta AI Unveils Next-Gen AI Capabilities for Universities
  • A Rare Gem Shines: The Story of The Queen Diamond
  • MY01 Welcomes Joe Kiani to Pave the Way in Patient Health
  • Qubrid AI Empowers Rapid GPU Cloud Provider Onboarding
  • Major Expansion Planned for Montreal Port's ContrecĹ“ur Terminal
  • Rep. Byron Donalds Sells Deckers Outdoor Stock in Recent Trade
  • Transforming $100 Into Substantial Returns with IBM Stock
  • Exploring Recent Insider Transactions at FitLife Brands Inc
  • Congressman Discloses Significant IBM Stock Transaction
  • Shift in Consumer Spending: Wealthier Shoppers Lead Market Trends
  • SiriusXM and Howard Stern: An Entertainment Powerhouse Together
  • Exploring the Remarkable Growth of CrowdStrike Holdings Over 5 Years
  • Analysts Spotlight: Top Stock Picks from Leading Wall Street Experts
  • Pension Fund Growth Reaches New Heights in Global Landscape
  • Analyzing NVIDIA's Position Among Semiconductor Rivals
  • Aryna Sabalenka Triumphs at US Open: A Celebration of IM8
  • Unraveling Microsoft's Competitive Edge in Software Market
  • Society Pass Inc. Achieves Compliance with Nasdaq's Rules
  • HCA Healthcare Stock Analysis: P/E Insights and Trends
  • Understanding Meta Platforms' Competitive Edge in Media Sector
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site